Skip to main content

Davis Polk & Wardwell and Zhong Lun Law Firm advised Chinese biopharmaceutical company Antengene Corporation on its $335 million IPO in Hong Kong, with Herbert Smith Freehills and Commerce & Finance Law Offices advising the joint sponsors and the underwriters.

Antengene is a clinical-stage Asia-Pacific biopharmaceutical company offering R&D capabilities and oncology therapies.

The listing is the latest by a Chinese biopharmaceutical company in Hong Kong, which has seen a flurry of such IPOs. Recent other issuers include Simcere Pharmaceutical Group, JHBP (CY) Holdings and Everest Medicines.

The Herbert Smith Freehills team was led by Matt Emsley and Stanley Xie.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

S&R, CAM act on $980 mln Roadstar Infra InvIT listing

by Nimitt Dixit |

Indian law firm S&R Associates has advised Infrastructure Leasing & Financial Services subsidiary Roadstar Infra Investment Trust, its sponsor Roadstar Infra and Roadstar Investment Managers in the listing of 455.4 million InvIT units at a valuation of approximately $980 million.

Deals

SAM, JSA advise on Bajaj Group's $2.8 bln buyout of Allianz's stake in insurance JV

by Nimitt Dixit |

Shardul Amarchand Mangaldas & Co. has advised Bajaj Finserv on the proposed acquisition of Allianz SE's entire 26 percent promoter stake in their insurance joint ventures, Bajaj Allianz General Insurance Company (BAGIC) and Bajaj Allianz Life Insurance Company (BALIC).

Deals

Trilegal, CAM advise on $900 mln Brookfield-Gentari deal amid renewable M&A surge

by Nimitt Dixit |

Trilegal and Cyril Amarchand Mangaldas have advised on Brookfield Asset Management's $900 million sale of a 1.6 GW portfolio of solar and wind assets in India to Gentari Renewables India, a Petronas Group company.